Lincomycin, clindamycin and their applications
暂无分享,去创建一个
[1] B. J. Magerlein. Modification of lincomycin. , 1971, Advances in applied microbiology.
[2] B. Meyers,et al. Susceptibilities of Gram-Negative Bacteria to Combinations of Antimicrobial Agents In Vitro , 1975, Antimicrobial Agents and Chemotherapy.
[3] J. Klastersky,et al. Bactericidal Activity of the Combinations of Gentamicin with Clindamycin or Chloramphenicol Against Species of Escherichia coli and Bacteroides fragilis , 1977, Antimicrobial Agents and Chemotherapy.
[4] G. Ridgway,et al. The antimicrobial susceptibility of Chlamydia trachomatis in cell culture. , 1978, The British journal of venereal diseases.
[5] F. Cox. Human babesiosis , 1980, Nature.
[6] R. Goering,et al. Effects of clindamycin on derepression of β-lactamases in Gram-negative bacteria , 1983 .
[7] R. Goering,et al. Effects of clindamycin on derepression of beta-lactamases in gram-negative bacteria. , 1983, The Journal of antimicrobial chemotherapy.
[8] P. Schlievert,et al. Clindamycin-induced suppression of toxic-shock syndrome--associated exotoxin production. , 1984, The Journal of infectious diseases.
[9] D. Eschenbach,et al. [Bacterial vaginosis]. , 1985, Archives of gynecology.
[10] I. Phillips,et al. Activity of clindamycin against Staphylococcus aureus and Staphylococcus epidermidis from four UK centres. , 1991, The Journal of antimicrobial chemotherapy.
[11] F. Baquero,et al. Resistance of Peptostreptococcus spp. to macrolides and lincosamides: inducible and constitutive phenotypes , 1992, Antimicrobial Agents and Chemotherapy.
[12] Inducible expression of ribosomal clindamycin resistance in Bacteroides vulgatus , 1992, Antimicrobial Agents and Chemotherapy.
[13] J. Ballesta,et al. Antibiotic sensitivity of ribosomes from wild-type and clindamycin resistant Bacteroides vulgatus strains. , 1992, The Journal of antimicrobial chemotherapy.
[14] I. Brook,et al. Significant recovery of nonsporulating anaerobic rods from clinical specimens. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] C. Ryan,et al. Flavobacterial sepsis in massively burned pediatric patients. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] M. Gourdeau,et al. Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers , 1994, Antimicrobial Agents and Chemotherapy.
[17] I. Podglajen,et al. Multicentre survey in France of the antimicrobial susceptibilities of 416 blood culture isolates of the Bacteroides fragilis group. , 1994, The Journal of antimicrobial chemotherapy.
[18] K. Watanabe,et al. Antibiotic susceptibility profiles of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan from 1990 to 1992. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] D. Roos,et al. In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii , 1995, Antimicrobial agents and chemotherapy.
[20] J. Knapp,et al. Susceptibilities of Chlamydia trachomatis isolates causing uncomplicated female genital tract infections and pelvic inflammatory disease , 1995, Antimicrobial agents and chemotherapy.
[21] O. Dupuy,et al. Antibiotiques et paludisme. Revue de la littérature , 1995 .
[22] D. Roos. Molecular genetic tools for the identification and analysis of drug targets in Toxoplasma gondii. , 1996, Current topics in microbiology and immunology.
[23] H. B. Fung,et al. Treatment regimens for patients with toxoplasmic encephalitis. , 1996, Clinical therapeutics.
[24] A. Bouvet. Infections sévères dues à Streptococcus pyogenes ou streptocoque du groupe A , 1996 .
[25] U. Groß,et al. Influence of antimicrobial agents on replication and stage conversion of Toxoplasma gondii. , 1996, Current topics in microbiology and immunology.
[26] E. Wald,et al. Emerging resistance to antibiotics: impact on respiratory infections in the outpatient setting. , 1996, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[27] S. Ōmura,et al. Semisynthetic modification of antibiotic lincomycin. , 1996, The Journal of antibiotics.
[28] L. Bastian,et al. Bacillus-cereus-Pneumonie nach Thoraxtrauma. Fallbeispiel und Literaturübersicht , 1997 .
[29] N. F. Jacobs,et al. Drug-Induced Clostridium difficile-Associated Disease , 1997, Drug safety.
[30] A. ...,et al. The use of antibiotics : a clinical review of antibacterial, antifungal, and antiviral drugs , 1997 .
[31] R. Leblay,et al. La babésiose humaine en 1997 , 1997 .
[32] G. Regel,et al. [Bacillus cereus pneumonia after thoracic trauma. Case report and review of the literature]. , 1997, Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS.
[33] F. Schildberg,et al. Klebsiella pneumoniae Necrotizing F asciitis Associated w ith D iabetes a nd L iver C irrhosis , 2000 .
[34] N. Sadick,et al. Antimicrobial agents for the dermatologist. II. Macrolides, fluoroquinolones, rifamycins, tetracyclines, trimethoprim-sulfamethoxazole, and clindamycin. , 1997, Journal of the American Academy of Dermatology.
[35] P. Brasseur,et al. [Human babesiosis in 1997]. , 1997, La Revue de medecine interne.
[36] A. Cooper. Systematic review of Propionibacterium acnes resistance to systemic antibiotics , 1998, The Medical journal of Australia.
[37] M. Smieja,et al. Current indications for the use of clindamycin: A critical review. , 1998, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.
[38] J. Fishman. Treatment of Infection Due toPneumocystis carinii , 1998, Antimicrobial Agents and Chemotherapy.
[39] B. Mordmüller,et al. [Malaria therapy in the era of chloroquine resistance]. , 1998, Wiener klinische Wochenschrift.
[40] B. Allaouchiche,et al. [Diffusion in bone tissue of antibiotics]. , 1999, Presse medicale.
[41] C. Veyssier-Belot,et al. [Erysipelas, cellulitis and other severe Streptococcus pyogenes skin infections]. , 1999, Presse medicale.
[42] C. Noli,et al. Macrolides and lincosamides. , 1999, Veterinary dermatology.
[43] M. Wilcox,et al. Antibiotics and Clostridium difficile. , 1999, Microbes and infection.
[44] M. Matsuoka. [Study of macrolide, lincosamide, and streptogramin B antibiotics resistance in Staphylococcus aureus]. , 2000, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.
[45] M. Falagas,et al. Bacteroides, Prevotella, and Porphyromonas species: a review of antibiotic resistance and therapeutic options. , 2000, International journal of antimicrobial agents.
[46] D. Stevens. Streptococcal toxic shock syndrome associated with necrotizing fasciitis. , 2000, Annual review of medicine.
[47] G. Bertho,et al. Lincomycin and clindamycin conformations. A fragment shared by macrolides, ketolides and lincosamides determined from TRNOE ribosome-bound conformations. , 2000, Bioorganic & medicinal chemistry.
[48] W. S. Champney,et al. Specific Inhibition of 50S Ribosomal Subunit Formation in Staphylococcus aureus Cells by 16-Membered Macrolide, Lincosamide, and Streptogramin B Antibiotics , 2000, Current Microbiology.
[49] J. French,et al. Bacterial vaginosis in pregnancy. , 2000, Obstetrical & gynecological survey.
[50] P. Conrad,et al. Human babesiosis: an emerging tick-borne disease. , 2000, International journal for parasitology.
[51] C. Stratton. Mechanisms of bacterial resistance to antimicrobial agents. , 2000, Le Journal medical libanais. The Lebanese medical journal.
[52] B. Forbes,et al. Activation of clindamycin phosphate by human skin , 2001, Journal of applied microbiology.
[53] J. Distler,et al. Aminoglycosides and Sugar Components in Other Secondary Metabolites , 2001 .
[54] F. Schluenzen,et al. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria , 2001, Nature.
[55] E. Mylonakis,et al. Clostridium difficile--Associated diarrhea: A review. , 2001, Archives of internal medicine.
[56] A. Bryskier. Anti-anaerobic activity of antibacterial agents , 2001, Expert opinion on investigational drugs.
[57] G. Plosker,et al. Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne. , 2002, American journal of clinical dermatology.
[58] C. Walker,et al. Rationale for use of antibiotics in periodontics. , 2002, Journal of periodontology.
[59] I. Brook. The prophylaxis and treatment of anthrax. , 2002, International journal of antimicrobial agents.
[60] B. Lell,et al. Clindamycin as an Antimalarial Drug: Review of Clinical Trials , 2002, Antimicrobial Agents and Chemotherapy.
[61] P. Hsueh,et al. High Incidence of Cefoxitin and Clindamycin Resistance among Anaerobes in Taiwan , 2002, Antimicrobial Agents and Chemotherapy.
[62] G. Plosker,et al. Clindamycin/Benzoyl Peroxide Gel , 2002 .
[63] I. Brook. Clinical review: Bacteremia caused by anaerobic bacteria in children , 2002, Critical care.
[64] K. Hikosaka,et al. Photoinactivation and recovery of photosystem II in Chenopodium album leaves grown at different levels of irradiance and nitrogen availability. , 2002, Functional plant biology : FPB.
[65] A. Frank,et al. Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children , 2003, Current opinion in infectious diseases.
[66] M. Stevenson,et al. Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. , 2003, The Journal of antimicrobial chemotherapy.
[67] H. Hahn,et al. Susceptibilities of Campylobacter jejuni Isolates from Germany to Ciprofloxacin, Moxifloxacin, Erythromycin, Clindamycin, and Tetracycline , 2003, Antimicrobial Agents and Chemotherapy.
[68] P. Branny,et al. Detection and characterization of feline Bartonella henselae in the Czech Republic. , 2003, Veterinary microbiology.
[69] G. Macfarlane,et al. Nondigestible Oligosaccharides Enhance Bacterial Colonization Resistance against Clostridium difficile In Vitro , 2003, Applied and Environmental Microbiology.
[70] Elizabeth A. Coyle. Targeting Bacterial Virulence: The Role of Protein Synthesis Inhibitors in Severe Infections , 2003, Pharmacotherapy.
[71] T. Řezanka,et al. Lincomycin, cultivation of producing strains and biosynthesis , 2004, Applied Microbiology and Biotechnology.
[72] M. Maekawa,et al. Detection of Macrolide Resistance in Streptococcus pneumoniae , 2003, Chemotherapy.
[73] W J Cunliffe,et al. Antibiotic‐resistant acne: lessons from Europe , 2003, The British journal of dermatology.
[74] H. Bartels,et al. Antibiotics acting on the translational machinery , 2003, Journal of Cell Science.
[75] D. Guay. Treatment of bacterial skin and skin structure infections , 2003, Expert opinion on pharmacotherapy.
[76] K. Carroll,et al. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[77] I. Vass,et al. The interaction of visible and UV-B light during photodamage and repair of Photosystem II , 2004, Photosynthesis Research.
[78] R. Vanholder,et al. Immunomodulating effects of antibiotics: Literature review , 1996, Infection.